| Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
| 16/07/2024 | UBS Group AG | 1104(L) | +473,693(L) | 10,105,936(L) 4,673,313(S) | 6.18 2.86 | |
| 11/07/2024 | UBS Group AG | 1305(L) | 4,647,176(L) | 9,345,634(L) 4,673,313(S) | 5.72 2.86 | |
| 10/07/2024 | UBS Group AG | 1004(L) | +1,015,105(L) | 9,160,718(L) 4,673,313(S) | 5.61 2.86 | |
| 10/07/2024 | Lin Lijun | 1101(L) | +1,112,500(L) | HKD22.824(L) | 9,155,732(L) | 5.60 |
| 08/07/2024 | Lin Lijun | 1101(L) | +1,112,500(L) | HKD22.828(L) | 9,155,732(L) | 5.60 |
| 30/06/2024 | Fosun International Holdings Ltd. | 1710(L) | 32,331,100(L) | 19.78 | ||
| 30/06/2024 | Guo Guangchang | 1710(L) | 32,331,100(L) | 19.78 | ||
| 30/06/2024 | Fosun International Limited | 1710(L) | 32,331,100(L) | 19.78 | ||
| 30/06/2024 | Fosun Industrial Co., Limited | 1701(L) | 32,331,100(L) | 19.78 | ||
| 30/06/2024 | Shanghai Fosun High Technology (Group) Co., Ltd. | 1710(L) | 32,331,100(L) | 19.78 | ||
| 30/06/2024 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1710(L) | 32,331,100(L) | 19.78 | ||
| 30/06/2024 | Fosun Holdings Limited | 1710(L) | 32,331,100(L) | 19.78 | ||
| 09/05/2024 | Qatar Investment Authority | 1201(L) | -80,700(L) | HKD17.240(L) | 13,055,859(L) | 7.99 |
| 1 2 3 4 5 | ||||||
| Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
| Real time quote last updated: 30/10/2025 08:47 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |